- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06583265
Impact of Endometrial Compaction on Clinical Pregnancy Rate in Frozen Embryo Transfers
September 1, 2024 updated by: Ain Shams University
To find out if the percentage of endometrial compaction is correlated to clinical pregnancy rate in down regulated frozen embryo transfer cycle.
Endometrial compaction is the change in endometrial thickness between the end of the estrogen only phase and the day of embryo transfer.
In concept, the compaction of the endometrium after progesterone initiation indicates that the endometrium is responsive to progesterone and could therefore be used as a proxy for endometrial receptivity predictability of FET cycle outcome
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
80
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Infertility patients planning for FET
Description
Inclusion Criteria:
- Women undergoing down regulated cycles frozen embryo transfer.
- Women at age group 20-35 years old.
- Day 5 embryos will be transferred.
Exclusion Criteria:
- Chromosomal abnormality in either partner (As this could lead to cycle cancellation).
- Uterine malformation or any intrauterine condition affecting the pregnancy outcomes of FET, such as endometrial polyps, uterine cavity adhesion, history of endometrial tuberculosis, hydrosalpinx with a reflux into uterine cavity (As the might not be candidates for IVF cycle till correction).
- Recurrent implantation failure, defined as 2 or more previous failed trials (Other confounding factors might of present which could affect the results).
- Cycles of patients with persistent endometrial thickness <7mm during treatment protocol (Due to cycled cancelation).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
clinical pregnancy rate
Time Frame: 3-4 wks after ET
|
Clinical pregnancy rate, determined by visualizing a viable embryo within the uterine cavity by ultrasound 3-4 weeks after ET, in patients with endometrial compaction in down regulated FET cycles in comparison to non endometrial compaction.
|
3-4 wks after ET
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percentage of change of endometrial thickness between the end of estrogen administration only phase and the day of embryo transfer.
Time Frame: 3-4 wks after ET
|
3-4 wks after ET
|
|
Chemical pregnancy rates, detected by positive hCG test in the absence of pregnancy findings on TVUS
Time Frame: 3-4 wks after ET
|
3-4 wks after ET
|
|
Number of estrogen administration days
Time Frame: 10 days before ET
|
10 days before ET
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
September 1, 2024
First Submitted That Met QC Criteria
September 1, 2024
First Posted (Actual)
September 4, 2024
Study Record Updates
Last Update Posted (Actual)
September 4, 2024
Last Update Submitted That Met QC Criteria
September 1, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Endometrial Compaction
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IVF
-
University of MelbourneCompletedIVF | IVF Treatment | IVF-ET | IVF/ICSIAustralia
-
Calla IVF CenterCompletedPregnancy Rate IVF | Blastocyst IVFRomania
-
Shady Grove Fertility Reproductive Science CenterNot yet recruiting
-
Clinia de fertilización Asistida en el Hospital...Not yet recruiting
-
Assaf-Harofeh Medical CenterRecruiting
-
Chinese University of Hong KongCompleted
-
Nicholas MacklonGedeon Richter Ltd.; IgenomixCompleted
-
One FertilityUnknown